{"text": "rt AT_USER xtandi price scrutiny hits as zytiga's strong os in '302 study helps it in pre-chemo setting. $jnj can fend off generics ti\u2026"}
{"text": "dow #stocks trend $ge $mmm $unh $trv $wmt $jnj $ko $ibm $mcd $cat $utx $xom $pg $vz $mrk $hd $cvx $v $csco $aapl @ URL"}
{"text": "rt AT_USER notable opening imbalances: $bac -157k, $c +101k, $ko -149k, $aa +128k, $pfe -55k, $jnj -31k, $nke -50k, $wmt -50k, $v -\u2026"}
